Statement Of Changes In Equity [Abstract]

BerGenBio - Filing #2542730

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
260,003,000 NOK
3,135,000 NOK
228,211,000 NOK
0 NOK
34,926,000 NOK
21,000 NOK
6,678,000 NOK
3,191,000 NOK
0 NOK
3,466,000 NOK
Share issue related cost
0 NOK
0 NOK
36,971,000 NOK
0 NOK
36,971,000 NOK
0 NOK
7,000 NOK
7,000 NOK
0 NOK
0 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.